Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 65 entries
View as:

Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06745024 Org: User:
Start: 04/14/25 End: 10/01/28 Due: 10/01/29

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Phase: N/A Priority: Normal
NCT ID: NCT05080673 Org: User:
Start: 02/09/22 End: 11/01/65 Due: 11/01/66

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03186898 Org: User:
Start: 01/26/18 End: 06/30/27 Due: 06/30/28

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02179086 Org: User:
Start: 12/04/14 End: 12/31/25 Due: 12/31/26

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT06500455 Org: User:
Start: 12/12/24 End: 06/30/28 Due: 06/30/29

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04068103 Org: User:
Start: 12/16/19 End: 06/21/26 Due: 06/21/27

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03180268 Org: User:
Start: 09/12/17 End: 06/15/27 Due: 06/15/28

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Phase: N/A Priority: Normal
NCT ID: NCT04513717 Org: User:
Start: 01/21/21 End: 12/31/33 Due: 12/31/34

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03180294 Org: User:
Start: 05/31/17 End: 02/22/21 Due: 02/22/22

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02206334 Org: User:
Start: 08/31/14 End: 05/20/22 Due: 05/20/23

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05624996 Org: User:
Start: 07/12/23 End: 10/15/31 Due: 10/15/32

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05896189 Org: User:
Start: 04/12/24 End: 11/30/27 Due: 11/30/28

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Phase: N/A Priority: Normal
NCT ID: NCT05879926 Org: User:
Start: 08/31/23 End: 07/31/34 Due: 07/31/35

Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05705401 Org: User:
Start: 03/13/23 End: 02/01/37 Due: 02/01/38

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Phase: N/A Priority: Normal
NCT ID: NCT04852887 Org: User:
Start: 06/07/21 End: 07/31/41 Due: 07/31/42

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase: N/A Priority: Normal
NCT ID: NCT02135042 Org: User:
Start: 04/21/14 End: 02/28/31 Due: 02/28/32

Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02315469 Org: User:
Start: 02/10/15 End: 02/09/19 Due: 02/09/20

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT05174169 Org: User:
Start: 03/10/22 End: 03/10/30 Due: 03/10/31

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03137771 Org: User:
Start: 04/07/17 End: 12/31/28 Due: 12/31/29

Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03860961 Org: User:
Start: 07/26/19 End: 11/14/26 Due: 11/14/27

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Phase: N/A Priority: Normal
NCT ID: NCT06500481 Org: User:
Start: 11/21/24 End: 07/31/33 Due: 07/31/34

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03274687 Org: User:
Start: 07/28/17 End: 08/03/25 Due: 08/03/26

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase: N/A Priority: Normal
NCT ID: NCT04037254 Org: User:
Start: 10/08/19 End: 09/26/25 Due: 09/26/26

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06958328 Org: User:
Start: 07/15/25 End: 10/21/30 Due: 10/21/31

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02316548 Org: User:
Start: 02/28/15 End: 02/01/17 Due: 02/01/18